Mustang Bio Inc (MBIO)

Currency in USD
0.601
+0.025(+4.35%)
Closed·
0.593-0.008(-1.33%)
·
MBIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.5610.653
52 wk Range
0.5251.880
Key Statistics
Prev. Close
0.575
Open
0.561
Day's Range
0.561-0.653
52 wk Range
0.525-1.88
Volume
74.32K
Average Volume (3m)
130.93K
1-Year Change
-63.8133%
Book Value / Share
1
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MBIO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Mustang Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Earnings

Latest Release
Aug 05, 2026
EPS / Forecast
-0.16 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MBIO Income Statement

Compare MBIO to Peers and Sector

Metrics to compare
MBIO
Peers
Sector
Relationship
P/E Ratio
−1.5x−1.9x−0.4x
PEG Ratio
−0.020.040.00
Price/Book
0.6x2.0x2.6x
Price / LTM Sales
-7.8x3.1x
Upside (Analyst Target)
-160.0%48.8%
Fair Value Upside
Unlock10.1%5.7%Unlock

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children’s hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
147.39K1.95%88.54K
Other Institutional Investors
2.05M27.10%1.23M
Public Companies & Retail Investors
5.38M70.96%3.23M
Total
7.58M100.00%4.55M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
City Of Hope11.16%845,385508
Fortress Biotech, Inc.7.07%535,577322

People Also Watch

6.700
NEXT
-1.47%
0.950
ORGN
0.00%
23.59
VRDN
+4.80%
0.35
NFE
+2.91%
1.95
BDTX
+1.56%

FAQ

What Is the Mustang Bio (MBIO) Stock Price Today?

The Mustang Bio stock price today is 0.601 USD.

What Stock Exchange Does Mustang Bio Trade On?

Mustang Bio is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Mustang Bio?

The stock symbol for Mustang Bio is "MBIO."

What Is the Mustang Bio Market Cap?

As of today, Mustang Bio market cap is 4.550M USD.

What Is Mustang Bio's Earnings Per Share (TTM)?

The Mustang Bio EPS (TTM) is -0.463.

From a Technical Analysis Perspective, Is MBIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Mustang Bio Stock Split?

Mustang Bio has split 2 times.

How Many Employees Does Mustang Bio Have?

Mustang Bio has 4 employees.

What is the current trading status of Mustang Bio (MBIO)?

As of Aug 09, 2026, Mustang Bio (MBIO) is trading at a price of 0.601 USD, with a previous close of 0.575 USD. The stock has fluctuated within a day range of 0.561 USD to 0.653 USD, while its 52-week range spans from 0.525 USD to 1.880 USD.

What Is the MBIO Premarket Price?

MBIO's last pre-market stock price is 0.560 USD. The pre-market share volume is 4,190.000, and the stock has decreased by -0.015, or -2.610%.

What Is the MBIO After Hours Price?

MBIO's last after hours stock price is 0.593 USD, the stock has decreased by -0.008, or -1.330%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.